NCT00838630View on ClinicalTrials.gov

Cilostazol 100 mg Tablet Formulations Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

November 30, 2003

Primary Completion Date

November 30, 2003

Study Completion Date

November 30, 2003

Conditions
Healthy
Interventions
DRUG

Cilostazol 100 mg tablets

1 x 100 mg

DRUG

Pletal® 100 mg tablets

1 x 100 mg

Trial Locations (1)

63301

Gateway Medical Research Inc., Saint Charles

All Listed Sponsors
lead

Teva Pharmaceuticals USA

INDUSTRY

NCT00838630 - Cilostazol 100 mg Tablet Formulations Under Fasting Conditions | Biotech Hunter | Biotech Hunter